17 Sep 21:
Update: another investor has followed Mr Lim's lead and bought more Daibochi shares rather than selling out to him: transactions on 15 Sept.
16 Sep 21:
'Here we go again...' new article on the latest attempt at a squeeze-out delisting, this time by Scientex for Daibochi. Inadequate price, unnecessary distraction. Surely in a pandemic it would be better to maintain good relationships and trust with all parties, rather than trying to take advantage of your own investors? Sigh. Minorities please note, the insiders think the shares undervalued... they want to buy...
12 Sep 21:
I have not read the book, temporarily out of stock, but this review may provide some idea of the issues with which Malaysians are grappling, and the background to the political crisis of the last 18 months which I am unqualified to discuss. Political changes have led to decisions which appear to be undermining the economic model of decades, without much policy debate. The stakes seem high; the floodwaters uncharted. Many people are working hard on mitigation and a rethink. Cyril Pereira on the new book by Dennis Ignatius. Thanks Asia Sentinel.
2 Sep 21:
The NAV of the Series A shares rose 6.4% in August, to US$ 2,758.31; charts.
2 Aug 21:
The NAV of the Series A shares fell 1.9% in July, to US$ 2,592.19; charts.
1 Aug 21:
Freedom of expression, honest criticism, and a fair legal system are vital for the maintenance of democracy, and to provide the necessary checks on corruption to enable long-term investment with confidence. Deficiencies and regression are often noted among the risk factors for emerging and frontier markets, but as a British citizen I am appalled by the jailing in the UK of Craig Murray. I have followed his thinking for many years, since he was ambassador in Uzbekistan. His judgment has been vindicated time and again, and he has given sterling service to society by reporting with unusual clarity and integrity on issues of vital importance. The precedent that this legal case sets is very dangerous. Jonathan Cook has stepped up to explain some of the background (the archives of Craig's blog provide more), and sees it as 'the latest move in a battle to snuff out independent journalism'.
Britain has now drawn the attention of the UN Special Rapporteur on Torture: 'if anyone in Scotland deserves to be called a «proper journalist» whose writing & integrity actually make a difference, it is @CraigMurrayOrg', and a Craig Murray Justice Campaign has been established: https://twitter.com/cmurrayjustice.
First they came for Craig Murray... fellow citizens, please take note.
18 Jul 21:
The National Unity Government of Myanmar (in exile) hopes for an independent non-political body to coordinate the Covid-19 response, and would engage with the junta to work on this crisis. For health professionals not previously familiar with Myanmar, the announcement by Dr Sasa will also provide some indication of the great and unusual challenges.
17 Jul 21:
Doctors in Myanmar have been bracing for Covid, and it has hit with the force of a tsunami. Very few of the casualties will be counted in official statistics; access to healthcare was always limited and many hospitals closed after the February coup. Supplies of medicine and equipment are scarce, and prices have been soaring. Please read today's article by Dr Mary Callahan. She quotes public health experts on the ground who predict that 50% of the population will be infected within three weeks, and that the ultimate Covid death toll could be 10-15 million people. The title speaks of 'Myanmar on the brink of decimation', and this seems all too feasible - but on a population of 55 million, 10-15m eventual deaths would represent a higher 15-30% of the population.
Twitter remains a good source for news, although often now relayed: Dr Callahan, #WhatsHappeningInMyanmar. The staff at Medical Action Myanmar are working around the clock. Please help if you can: support is so valuable.
16 Jul 21:
The 2Q report discusses 'Sustainability claims and delusions'.
The health situation arising from the Covid pandemic is alarming in much of the world, including South and Southeast Asia. Of the many charities rising to the occasion, there are two in particular that Apollo Investment Management has supported recently and that I'd like to bring to the attention of readers. Both seem highly effective, can put new money to immediate good use, and are of a scale where our readers can make a big difference. I'd be happy to discuss them with fellow donors - and to hear about your own priorities.
Medical Action Myanmar: https://mam.org.mm/
Adara Development: https://www.adaragroup.org/
1 Jul 21:
The NAV of the Series A shares rose 0.6% in June, to a fractional new high of US$ 2,641.82; charts.
1 Jun 21:
The NAV of the Series A shares rose 4.1% in May, to a new high of US$ 2,624.89; charts.
27 May 21:
The 2020 report of income for UK Reporting Fund purposes for the Series A shares is here. Despite COVID, the fund's income jumped last year due to the special dividend from Convenience Retail Asia, mentioned in our 4Q report. The page listing all of the income reports (starting 2013) is www.apolloinvestment.com/UKreportingfund.html.
14 May 21:
A 10-minute video from CNBC on sand mining, with speakers from the Global Resource Information Database of the UN Environment Programme, GRID-Geneva, and Kiran Pereira of Sand Stories. (We still recommend Kiran's book).
7 May 21:
I first wrote about Medical Action Myanmar after a visit six years ago, and noted the comment of Professor Sir Nick White that it was the most effective health NGO he had ever encountered. The endorsements of other supporters are well worth reading; Mercury Phoenix Trust has several short video reports on its YouTube channel. Regular health programmes are mostly funded by grants for specific purposes; private donations can be used more flexibly, wherever the health needs are greatest. As our readers will be able to imagine, those needs have multiplied by an order of magnitude, and steep increases in COVID cases in neighbouring countries suggest more challenges ahead. I have followed MAM's activities with admiration since 2015, have been more frequently in touch in recent months, and am ever more impressed. Please consider donating; feel free to contact me with donor-questions.
3 May 21:
The NAV of the Series A shares rose 3.3% in April, to a new high of US$ 2,520.60; charts.
22 Apr 21:
The 1Q report discusses 'Rips in the fabric'.
4 Apr 21:
The NAV of the Series A shares fell 1.5% in March, to US$ 2,439.32; charts here.
18 Mar 21:
As reporting from the ground in Myanmar dwindles, with repression of the media and longer internet cutoffs, readers may wish to follow the occasional statements of Dr Sasa, Special Envoy to the United Nations of the CRPH, the committee representing the elected & ousted NLD government-in-exile. After escaping the country, this is his eloquent defiance and denunciation of the junta.
In an excellent overview, Thant Myint-U explains the historic background & asks 'What next for Burma?'
15 Mar 21:
There are many political and social developments in Asia on which we no longer comment. Official sensitivities, and in places draconian gagging restrictions, encourage reticence; in any case it is usually easy to find commentators who are closer and more expert. However, the situation in Myanmar, very bad since the military coup on 1 Feb, has deteriorated drastically in the last couple of days, and I notice that the coverage in the newspapers on which some of you rely seems inadequate. The fund has no investments in Myanmar, but it is a country of immense strategic importance, summed up years ago in the succinct title of Thant Myint-U's book 'Where China Meets India'. Myanmar is a member of ASEAN, where today's rapidly changing editorial headlines show the diplomatic anxieties of governments themselves accustomed to suppressing dissent, and nervous about offending China or opposing commercial interests. Observers on the ground report casualties much higher than some newspapers are reporting, and there are allegations that false-flag provocations preceded the current brutal crackdown on protests which have for six weeks been determinedly peaceful. If only on human rights grounds, but also because these events may ultimately prove to have practical importance for us all, please pay some attention to https://twitter.com/hashtag/WhatsHappeningInMyanmar - and if you pray, include my friends at Medical Action Myanmar, still operating and grateful for donations, and their patients and the clinics I visited in the township of HlaingTharYar, today unfortunately seeing action.
2 Mar 21:
The NAV of the Series A shares rose 5.3% in February, to a new high of US$ 2,475.81; charts here.
22 Feb 21:
Apollo Asia Fund has a new administrator, ASCENT Fund Services (Singapore) Pte Ltd, with effect from 1 February; an e-mail was sent to investors on that day. The Fund's custodian is unchanged, Northern Trust.
2 Feb 21:
The NAV of the Series A shares fell 1.0% in January, to US$ 2,350.97; charts here.
17 Jan 21:
A report for 4Q has been posted: 'Sustainability Stories'.
12 Jan 21:
Malaysia has declared a state of emergency, attributed to COVID-19. Given global newsflow, investors pressed for time may wish to glance at the work of leading cartoonists for quick reflections of local sentiment. Apollo Asia Fund has less than 10% of NAV invested in Malaysia, in two companies. We do not expect these companies, or the investment manager (AIMS Asset Management Sdn Bhd), to be directly affected. Malaysians are understandably concerned about constitutional, political, social and economic consequences of the declaration, and long-term investors in assets such as infrastructure have already been unnerved by the cancellation of the high-speed railway link to Singapore, as well as by financial scandals and legal developments over the years. However, given the nature of AAF's two investments, we do not believe that AAF investors should worry unduly about this particular twist in the Malaysian political saga. If any investor in the Fund has particular concerns, please contact the fund manager, Claire Barnes.
5 Jan 21:
The NAV of the Series A shares rose another 4.7% in December, to a new high of US$ 2,375.43, so far undaunted by new Covid variants; charts here.
To What was new archive - 2020
To What was new archive - 2019
To What was new archive - 2018
To What was new archive - 2017
To What was new archive - 2016
To What was new archive - 2015
To What was new archive - 2014
To What was new archive - 2013
To What was new archive - 2012
To What was new archive - 2011
To What was new archive - 2010
To What was new archive - 2009
To What was new archive - 2008
To What was new archive - 2007
To What was new archive - 2006
To What was new archive - 2005
To What was new archive - 2004
To What was new archive - 2003
To What was new archive - 2002
To What was new archive - 2001
To What was new archive - 2000
To What was new archive - 1999
|Home||Investment philosophy||Fund performance||Reports & articles||*What's new?*|
|Why Apollo?||Who's Claire Barnes?||Fund structure||Poetry & doggerel||Contacts|